CINECA IRIS Institutional Research Information System

TISEO, GIUSY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.445
EU - Europa 666
AS - Asia 216
AF - Africa 65
SA - Sud America 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.435
IT - Italia 226
SE - Svezia 202
SG - Singapore 97
BG - Bulgaria 73
DE - Germania 56
CI - Costa d'Avorio 44
CN - Cina 43
GB - Regno Unito 41
AT - Austria 27
IN - India 26
VN - Vietnam 26
SN - Senegal 18
CZ - Repubblica Ceca 16
HK - Hong Kong 16
CA - Canada 10
AE - Emirati Arabi Uniti 5
AU - Australia 5
BR - Brasile 5
CH - Svizzera 3
FR - Francia 3
SK - Slovacchia (Repubblica Slovacca) 3
BE - Belgio 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
IE - Irlanda 2
AR - Argentina 1
EC - Ecuador 1
EU - Europa 1
FI - Finlandia 1
HU - Ungheria 1
JP - Giappone 1
MD - Moldavia 1
NG - Nigeria 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
TR - Turchia 1
UA - Ucraina 1
Totale 2.407
Salva come PNG Salva come JPEG
Città #
Chandler 230
Fairfield 157
New York 77
Seattle 74
Sofia 73
Woodbridge 71
Florence 68
Ashburn 64
Wilmington 64
Boardman 57
Houston 54
Princeton 54
Cambridge 51
Lawrence 46
Abidjan 44
Medford 35
London 29
Ogden 27
Vienna 27
Singapore 25
Boulder 24
Frankfurt am Main 21
Dakar 18
Pisa 18
Ann Arbor 17
Hong Kong 16
Bremen 15
Pune 15
Brno 14
Serra 14
San Diego 13
Stockholm 12
Dallas 11
Kent 11
Munich 11
Milan 10
Rome 9
Beijing 8
Dong Ket 8
Ottawa 8
Redwood City 8
Des Moines 6
Falls Church 6
Castelfranci 5
Dubai 5
Hyderabad 5
Cedar Knolls 4
Hebei 4
Norwalk 4
Vicopisano 4
Bern 3
Catania 3
Los Angeles 3
Lucca 3
Sydney 3
Urgnano 3
Ancona 2
Belo Horizonte 2
Bolzano 2
Bratislava 2
Brdo 2
Brescello 2
Brussels 2
Cairo 2
Cincinnati 2
Dublin 2
Esslingen am Neckar 2
Genoa 2
Jiaxing 2
Kilburn 2
Kolkata 2
Marina di Castagneto Carducci 2
Melbourne 2
Nanchang 2
Parma 2
Saint-Fons 2
Terranuova Bracciolini 2
Toronto 2
Acquasparta 1
Acton 1
Aprilia 1
Atlanta 1
Budapest 1
Buffalo 1
Capannori 1
Cascina 1
Changsha 1
Charlotte 1
Chehalis 1
Chisinau 1
Chongqing 1
Cittadella 1
Collegeville 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Cutrofiano 1
Dearborn 1
Denver 1
Dordrecht 1
Duncan 1
Totale 1.735
Salva come PNG Salva come JPEG
Nome #
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 111
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 100
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 97
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 87
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 86
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 85
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 81
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 76
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 73
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 59
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 59
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 57
Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli 56
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 56
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study 55
Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing enterobacterales during a regional outbreak 53
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 52
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 51
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 50
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 50
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 50
Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020 49
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 49
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 45
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 44
Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization 43
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 42
Considerations for the optimal management of antibiotic therapy in elderly patients 42
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 41
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy 39
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 39
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 38
Caring for older adults during the COVID-19 pandemic 38
Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification 37
Cefiderocol for the treatment of metallo-beta-lactamases producing Gram negative bacilli: lights and shadows from the literature 36
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 35
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 35
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 34
Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study 33
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 32
Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker? 30
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 28
Management of COVID patients with convalescent plasma: Do we have the final word? 27
Prevention of the spread of multidrug-resistant organisms in nursing homes 26
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 22
What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group 20
Characteristics of long-COVID among older adults: a cross-sectional study 19
Covid-19 early after renal transplantation: limitations and hazards of unproven therapies. Abstracts of the 20th Biennial European Society for Organ Transplantation (ESOT) Congress 19
Characteristics of long COVID among older adults: a cross-sectional study 18
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 15
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 14
Recrudescence of Plasmodium falciparum malaria 5 years after treatment in an HIV migrant: a case report with a peculiar presentation 14
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 14
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 13
Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis 10
Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients" 7
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 7
Totale 2.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 8 27 21 20 41 27 30 22 16 1
2020/2021280 10 6 5 8 10 14 71 29 38 20 35 34
2021/2022423 11 18 5 6 57 54 47 24 22 13 58 108
2022/2023878 83 97 77 81 84 111 13 69 167 2 87 7
2023/2024465 30 27 52 14 57 94 27 11 14 8 66 65
2024/2025110 28 78 4 0 0 0 0 0 0 0 0 0
Totale 2.498